Annual EPS
Summary
- Current Value
- As of today, NVAX annual EPS is -$1.23, up +77.22% on
- Historical Performance
- NVAX annual EPS is up +94.74% over the past 3 years, and up +77.62% over the past 5 years
- All-Time High Comparison
- NVAX annual EPS vs all-time high is unknown
- 3-Year Low Comparison
- NVAX annual EPS is +85.36% above its 3-year low of -$8.42 reached on an earlier date
- Sector Comparison
- NVAX annual EPS is higher than 51.03% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate NVAX annual EPS at $2.15, +274.40% higher than the current value
- Upcoming Earnings
- The next annual earnings release for NVAX is on
EPS Chart
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EPS | -$1.23 | +77.2% | +94.7% | +77.6% | +86.3% | |
| Quarterly EPS | -$1.25 | -64.5% | +42.1% | +61.1% | +37.7% | |
| TTM EPS | $1.77 | +178.3% | +110.2% | +133.9% | +119.7% | |
| Price | $7.78 | -9.0% | -36.7% | -93.9% | -84.5% | |
| Annual Revenue | $682.16M | -30.6% | -40.5% | +3555.3% | +10000.0% | |
| PE Ratio | 4.40 | – | – | – | – | |
| Annual Net Income | -$187.50M | +65.6% | +89.3% | -41.3% | -388.6% | |
| Annual Gross Profit | $484.22M | -31.2% | -57.3% | +100.0% | +100.0% | |
| Shares Outstanding | 162.50M | +1.3% | +88.9% | +129.0% | – |
EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$1.23 | at high | |
| 5Y | -$1.23 | at high | |
| All | $0.00 | N/A |
EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$8.42 | N/A | +85.4% |
| 5Y | -$23.44 | +94.7% | |
| All | -$23.44 | +94.7% |
EPS Estimates
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.21 | -$5.41 | -28.48% | |
| -$1.33 | -$1.23 | +7.69% | |
| $2.15 | N/A | +274.40% | |
| $0.29 | N/A | +123.38% |
🔒 Log In To Unlock Full Data
EPS History
FAQ
What is the current annual EPS of NVAX?
As of today, NVAX annual EPS is -$1.23
What is 1-year change in NVAX annual EPS?
NVAX annual EPS is up +77.22% year-over-year
What is 3-year change in NVAX annual EPS?
NVAX annual EPS is up +94.74% over the past 3 years
How far is NVAX annual EPS from its all-time high?
NVAX annual EPS vs all-time high is unknown
How does NVAX annual EPS rank versus sector peers?
NVAX annual EPS is higher than 51.03% of companies in Healthcare sector
How does the analyst estimate for NVAX annual EPS compare to its current value?
Analysts estimate NVAX annual EPS at $2.15, +274.40% higher than the current value
When is NVAX next annual earnings release?
The next annual earnings release for NVAX is on
Quarterly EPS
Summary
- Current Value
- As of today, NVAX quarterly EPS is -$1.25, down -307.40% on
- Historical Performance
- NVAX quarterly EPS is down -64.47% year-over-year, and up +42.13% over the past 3 years
- All-Time High Comparison
- NVAX quarterly EPS is currently -117.31% below its historical high of $7.20 set on
- 3-Year Low Comparison
- NVAX quarterly EPS is +63.46% above its 3-year low of -$3.41 reached on
- Sector Comparison
- NVAX quarterly EPS is higher than 15.35% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate NVAX quarterly EPS at -$0.49, +60.40% higher than the current value
- Upcoming Earnings
- The next earnings release for NVAX is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EPS | -$1.25 | -307.4% | -64.5% | +42.1% | +61.1% | |
| Annual EPS | -$1.23 | – | +77.2% | +94.7% | +77.6% | |
| TTM EPS | $1.77 | -21.6% | +178.3% | +110.2% | +133.9% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| Quarterly Revenue | $70.45M | -70.5% | -16.6% | -90.4% | -55.1% | |
| PE Ratio | 4.40 | -12.7% | – | – | – | |
| Quarterly Net Income | -$202.38M | -290.0% | -66.8% | -20.0% | -2.6% | |
| Quarterly Gross Profit | $50.65M | -77.5% | +97.1% | -82.6% | +100.0% | |
| Shares Outstanding | 162.50M | – | +1.3% | +88.9% | +129.0% |
Quarterly EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.92 | -142.7% | |
| 3Y | $2.92 | -142.7% | |
| 5Y | $2.92 | -142.7% | |
| All | $7.20 | -117.3% |
Quarterly EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.25 | at low | |
| 3Y | -$3.41 | +63.5% | |
| 5Y | -$11.18 | +88.8% | |
| All | -$11.18 | +88.8% |
Quarterly EPS Estimates
| Month | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.08 | $0.60 | +871.50% | |
| -$0.92 | -$1.25 | -35.98% | |
| -$0.49 | N/A | +60.40% | |
| $0.00 | N/A | +100.00% |
🔒 Log In To Unlock Full Data
Quarterly EPS History
FAQ
What is the current quarterly EPS of NVAX?
As of today, NVAX quarterly EPS is -$1.25
What is NVAX quarterly EPS most recent change?
NVAX quarterly EPS was down -307.40% on September 30, 2025
What is 1-year change in NVAX quarterly EPS?
NVAX quarterly EPS is down -64.47% year-over-year
How far is NVAX quarterly EPS from its all-time high?
NVAX quarterly EPS is currently -117.31% below its historical high of $7.20 set on December 31, 1996
How does NVAX quarterly EPS rank versus sector peers?
NVAX quarterly EPS is higher than 15.35% of companies in Healthcare sector
How does the analyst estimate for NVAX quarterly EPS compare to its current value?
Analysts estimate NVAX quarterly EPS at -$0.49, +60.40% higher than the current value
When is NVAX next earnings release?
The next earnings release for NVAX is on
TTM EPS
Summary
- Current Value
- As of today, NVAX TTM EPS is $1.77, down -21.65% on
- Historical Performance
- NVAX TTM EPS is up +178.26% year-over-year, and up +110.19% over the past 3 years
- All-Time High Comparison
- NVAX TTM EPS is currently -33.28% below its historical high of $2.65 set on
- 3-Year Low Comparison
- NVAX TTM EPS is +112.30% above its 3-year low of -$14.38 reached on
- Sector Comparison
- NVAX TTM EPS is higher than 90.01% of companies in Healthcare sector
- Analyst Estimate
- Analysts estimate NVAX TTM EPS at $1.78, +0.68% higher than the current value
- Upcoming Earnings
- The next earnings release for NVAX is on
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EPS | $1.77 | -21.6% | +178.3% | +110.2% | +133.9% | |
| Quarterly EPS | -$1.25 | -307.4% | -64.5% | +42.1% | +61.1% | |
| Annual EPS | -$1.23 | – | +77.2% | +94.7% | +77.6% | |
| Price | $7.78 | -12.7% | -9.0% | -36.7% | -93.9% | |
| TTM Revenue | $1.06B | -1.3% | +20.3% | -42.4% | +420.0% | |
| PE Ratio | 4.40 | -12.7% | – | – | – | |
| TTM Net Income | $341.75M | -19.2% | +220.0% | +125.8% | +225.4% | |
| TTM Gross Profit | $964.55M | +2.7% | +62.8% | -12.3% | +100.0% | |
| Shares Outstanding | 162.50M | – | +1.3% | +88.9% | +129.0% |
TTM EPS Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.65 | -33.3% | |
| 3Y | $2.65 | -33.3% | |
| 5Y | $2.65 | -33.3% | |
| All | $2.65 | -33.3% |
TTM EPS Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$1.32 | N/A | +233.7% |
| 3Y | -$14.38 | +112.3% | |
| 5Y | -$23.30 | +107.6% | |
| All | -$23.30 | +107.6% |
TTM EPS History
FAQ
What is the current TTM EPS of NVAX?
As of today, NVAX TTM EPS is $1.77
What is NVAX TTM EPS most recent change?
NVAX TTM EPS was down -21.65% on September 30, 2025
What is 1-year change in NVAX TTM EPS?
NVAX TTM EPS is up +178.26% year-over-year
How far is NVAX TTM EPS from its all-time high?
NVAX TTM EPS is currently -33.28% below its historical high of $2.65 set on March 31, 2025
How does NVAX TTM EPS rank versus sector peers?
NVAX TTM EPS is higher than 90.01% of companies in Healthcare sector
How does the analyst estimate for NVAX TTM EPS compare to its current value?
Analysts estimate NVAX TTM EPS at $1.78, +0.68% higher than the current value
When is NVAX next earnings release?
The next earnings release for NVAX is on
EPS Formula
Data Sources & References
- NVAX Official Website www.novavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1000694/000100069425000046/0001000694-25-000046-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000694/000100069425000004/0001000694-25-000004-index.htm
- NVAX Profile on Yahoo Finance finance.yahoo.com/quote/NVAX
- NVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvax
